Finland· FI-REL-REL8206

Razin

A piperazine product, registered in Finland by Schering Oy.

ATC P02CB01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedRazinATCP02CB01REGISTER NO.FI-REL-REL8206PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Manufacturer
Schering Oy
Country
Finland (FI)
ATC code
P02CB01
ATC class
Piperazine
Defined daily dose
3.5 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

14 interactions on record for piperazine.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Piperazine · interactions on record

14 records

  • 5 severe
  • 9 moderate

Most severe, free to view

  • TramadolN02AX02severe
  • BupropionN06AX12severe
  • BupropionN07BA02severe
  • IohexolV08AB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under P02CB01

Piperazine, as other registers publish it.

All piperazine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3c5fa2b3-13cf-4b28-8002-463848607ece
GET /v1/drugs/3c5fa2b3-13cf-4b28-8002-463848607ece?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "3.5",
  "form": "mikstuura",
  "route": null,
  "ddd_unit": "g",
  "strength": "150 mg/ml",
  "atc_label": "piperatsiini",
  "ma_number": "9071",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL8206",
  "authorised_at": "1985-08-07"
}

See everything about piperazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.